Skip to main content
. 2020 Feb 20;8(2):e16153. doi: 10.2196/16153

Table 2.

Population counts (n), proportions (%), and odds ratios of variables in the points-based scoring system for dry eye disease.

Factors Healthy, n (%) Dry eye disease, n (%) ORa (95% CI) P value
Sex/gender

Men 16,277,579 (54.19) 911,587 (25.90) Reference Reference

Women 13,761,300 (45.81) 2,607,754 (74.10) 2.6 (1.8-3.6) <.001
Perceived stress

None to a little 21,872,165 (72.81) 2,177,913 (61.88) Reference Reference

Much to extreme 6,864,096 (22.85) 1,202,940 (34.18) 1.6 (1.2-2.0) <.001
Eye surgery

None 26,673,187 (88.80) 2,701,904 (76.77) Reference Reference

Cataract 1,185,785 (3.95) 276,588 (7.86) 1.8 (1.2-2.6) .004

Corneal refractive 1,150,662 (3.83) 339,857 (9.66) 2.8 (1.7-4.6) <.001

Other 1,029,243 (3.43) 200,991 (5.71) 1.6 (1.0-2.5) .08
Rhinitis on inspection

No 21,295,695 (70.89) 2,180,596 (61.96) Reference Reference

Yes 8,047,298 (26.79) 1,243,634 (35.34) 1.5 (1.2-2.0) .001
Lipid-lowering medications

No 27,360,794 (91.08) 3,087,286 (87.72) Reference Reference

Yes 1,315,445 (4.38) 282,072 (8.01) 1.5 (1.1- 2.0) .02
Age (year)

<54 or ≥66 25,121,235 (83.63) 2,757,338 (78.35) Reference Reference

54-66 4,917,644 (16.37) 762,003 (21.65) 1.4 (1.1-2.0) .02
Current depression

No 25,591,681 (85.20) 2,616,142 (74.34) Reference Reference

Yes 456,573 (1.52) 153,162 (4.35) 1.9 (1.1-3.3) .02
Omega-3 intake (kcal/day)

<0.43% or >0.65% 13,804,921 (45.96) 1,812,313 (51.50) Reference Reference

0.43%-0.65% 10,414,321 (34.67) 857,985 (24.38) 0.7 (0.5-1.0) .04
Phosphorus intake (mg/day)

≥746 19,948,841 (66.41) 1,940,991 (55.15) Reference Reference

<746 4,270,401 (14.22) 729,307 (20.72) 1.4 (1.0-2.0) .09
Current smoker

No 21,334,370 (71.02) 2,950,840 (83.85) Reference Reference

Yes 7,399,648 (24.63) 430,013 (12.22) 0.7 (0.5-1.1) .14
Cholesterol intake (mg/day)

<240 12,037,627 (40.07) 1,575,001 (44.75) Reference Reference

≥240 12,181,614 (40.55) 1,095,296 (31.12) 0.9 (0.7-1.2) .57

aOR: odds ratio.